Abstract
The retinoblastoma protein (Rb) is a ubiquitous transcriptional repressor and a negative regulator of the Gl-to-S phase transition in the eukaryotic cell cycle. Through this inhibitory activity, Rb plays a critical role in suppressing neoplastic transformation and is disrupted in most cancers, either by mutation of the Rb gene (Lee et al. 1988; Shew et al. 1989; Bookstein et al. 1990; Kubota et al. 1995), or by functional inactivation of Rb by hyperphosphorylation (Sherr 1996). DNA tumor viruses transform cells, at least in part, by expressing oncoproteins such as adenovirus Ela, SV40 large tumor antigen, and human papillomavirus (HPV) E7 which bind and inactivate Rb (Decaprio et al. 1988; Dyson et al. 1989). In addition, Rb plays an important role in development as underscored by the embryonic lethal phenotype of Rb(−) knockout mice (Clarke et al. 1992; Jacks et al. 1992; Lee et al. 1992). The transcriptional repression by Rb is dependent on interaction of Rb with various corepressors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, Bertino JR, Wahl GM (1995) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 92: 5436–5440
Bagby S, Kim S, Maldonado E, Tong KI, Reinberg D, Ikura M (1995) Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein. Cell 82: 857–867
Bandara LR, La Thangue NB (1991) Adenovirus Ela prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351: 494–497
Blake MC, Azizkhan JC (1989) Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol 9: 4994–5002
Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee WH (1990) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762–7766
Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597–601
Bremner R, Cohen BL, Sopta M, Hamel PA, Ingles CJ, Gallie BL, Phillips RA (1995) Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol 15: 3256–3265
Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN (1995) The crystal structure of cyclin A. Structure 3: 1235–1247
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053–1061
Chen PL, Scully P, Shew JY, Wang JY, Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193–1198
Chow KN, Dean DC (1996) Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol 16: 4862–4868
Chow KN, Starostik P, Dean DC (1996) The Rb family contains a conserved cyclin-dependent-kinaseregulated transcriptional repressor motif. Mol Cell Biol 16: 7173–7181
Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330
Dalton S (1992) Cell cycle regulation of the human cdc2 gene. Embo J 11: 1797–1804
DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275–283
Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP (1994) The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119–130
Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245–2262
Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937
Felsenfeld G (1992) Chromatin as an essential part of the transcriptional mechanism. Nature 355:219–224 Gius DR, Ezhevsky SA, Becker-Hapak M, Nagahara H, Wei MC, Dowdy SF (1999) Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late GI. Cancer Res 59: 2577–2580
Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389: 349–352
Harbour JW (1998) Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening. Ophthalmology 105: 1442–1447
Harbour JW, Luo RX, Dei Sante A, Postigo AA, Dean DC (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98: 859–869
Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341–347
Hassig CA, Schreiber SL (1997) Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1: 300–308
Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43–48
Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A (1992) A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337–350
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993–1006
Hu QJ, Dyson N, Harlow E (1990) The regions of the retinoblastoma protein needed for binding to adenovirus E1 A or SV40 large T antigen are common sites for mutations. Embo J 9: 1147–1155
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359: 295–300
Kaelin JWG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA (1992) Expression cloning of a eDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351–364
Kim HY, Cho Y (1997) Structural similarity between the pocket region of retinoblastoma tumour suppressor and the cyclin-box. Nat Struct Biol 4: 390–395
Kingston RE, Narlikar GJ (1999) ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 13: 2339–2352
Kubota Y, Fujinami K, Uemura H, Dobashi Y, Miyamoto H, Iwasaki Y, Kitamura H, Shuin T (1995) Retinoblastoma gene mutations in primary human prostate cancer. Prostate 27: 314–320
Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89: 349–356
Lai A, Lee JM, Yang WM, DeCaprio JA, Kaelin WG Jr, Seto E, Branton PE (1999) RBPI recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol 19: 6632 6641
Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A (1992) Mice deficient for
Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288–294
Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH (1988) Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218–221
Lee JO, Russo AA, Pavletich NP (1998) Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391: 859–865
Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394–1399
Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753–761
Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92: 463 473
Magnaghi JL, Groisman R, Naguibneva I, Robin P, Lorain S, Le VJ, Troalen F, Trouche D, Harel BA (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601–605
Meloni AR, Smith EJ, Nevins JR (1999) A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc Natl Acad Sci USA 96: 9574–9579
Nevins JR (1998) Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 9: 585–593
Nibu Y, Zhang H, Levine M (1998) Interaction of short-range repressors with Drosophila CtBP in the embryo. Science 280: 101–104
Ohtani K, DeGregori J, Nevins JR (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 92: 12146–12150
Qian Y, Luckey C, Horton L, Esser M, Templeton DJ (1992) Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12: 5363–5372
Ross JF, Liu X, Dynlacht BD (1999) Mechanism of transcriptional repression of E2F by the retino-blastoma tumor suppressor protein. Mol Cell 3: 195–205
Schaeper U, Subramanian T, Lim L, Boyd JM, Chinnadurai G (1998) Interaction between a cellular protein that binds to the C-terminal region of adenovirus El A ( CtBP) and a novel cellular protein is disrupted by EI A through a conserved PLDLS motif. J Biol Chem 273: 8549–8552
Sellers WR, Rodgers JW and Kaelin WJ (1995) A potent transrepression domain in the retino-blastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA 92: 11544–11548
Shan B, Farmer AA, Lee WH (1996) The molecular basis of E2F-l/DP-l-induced S-phase entry and apoptosis. Cell Growth Differ 7: 689–697
Shan B, Lee WH (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14: 8166–8173
Sherr CJ (1996) Cancer cell cycles. Science 274: 1672–1677
Shew JY, Ling N, Yang XM, Fodstad O, Lee WH (1989) Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (ppl IORB) in osteosarcomas and synovial sarcomas. Oncogene Res 4: 205–214
Templeton DJ, Park SH, Lanier L, Weinberg RA (1991) Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci USA 88: 3033–3037
Thalmeier K, Synovzik H, Mertz R, Winnacker EL, Lipp M (1989) Nuclear factor E2F mediates basic transcription and trans-activation by Ela of the human MYC promoter. Genes Dev 3: 527–536
Trouche D, Le CC, Muchardt C, Yaniv M, Kouzarides T (1997) RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci USA 94: 11268–11273
Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T (1998) Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2: 293–304
Tyler JK, Kadonaga JT (1999) The “dark side” of chromatin remodeling: repressive effects on transcription. Cell 99: 443–446
Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375: 812–815
Weintraub SJ, Prater CA, Dean DC (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259–261
Zhang HS, Postigo AA, Dean DC (1999) Active transcriptional repression by the Rb-E2F complex mediates GI arrest triggered by pl6INK4a, TGF(3, and contact inhibition. Cell 97: 53–61
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Harbour, J.W., Dean, D.C. (2001). Corepressors and Retinoblastoma Protein Function. In: Privalsky, M.L. (eds) Transcriptional Corepressors: Mediators of Eukaryotic Gene Repression. Current Topics in Microbiology and Immunology, vol 254. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10595-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-10595-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-08709-7
Online ISBN: 978-3-662-10595-5
eBook Packages: Springer Book Archive